Chronic cholesterol crystal embolism with a spontaneous onset

Internal Medicine

Volumn 46, Issue 14, 2007, Pages 1123-1126

  Enomae, Mio ^a   Takeda, Shin Ichi ^a   Yoshimoto, Keiichi ^a   Takagawa, Kiyoshi ^a  

^a Kurobe City Hospital   (Japan)

Author keywords

Cholesterol crystal embolism; Chronic kidney disease; Corticosteroid; LDL apheresis; Renal biopsy

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA 2 MICROGLOBULIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; GADOLINIUM PENTETATE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISOLONE; PROSTAGLANDIN E1; PROTHROMBIN; TRIACYLGLYCEROL; WARFARIN;

AGED; APHERESIS; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CASE REPORT; CHOLESTEROL EMBOLISM; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY BIOPSY; KIDNEY DISEASE; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PATIENT REFERRAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTHROMBIN TIME; SKIN BIOPSY; TREATMENT OUTCOME; URINALYSIS;

AGED; ARTERIOSCLEROSIS OBLITERANS; CHRONIC DISEASE; CREATININE; DIAGNOSIS, DIFFERENTIAL; EMBOLISM, CHOLESTEROL; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; TREATMENT OUTCOME;

EID: 34548456477     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0102     Document Type: Article

References (12)

1. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology 38: 769-784, 1987.
2. Lye WC, Cheah IS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol 13: 489-493, 1993.
3. Thadhani RI, Camargo CA Jr, Xavier RJ, Fang LST, Bazari H. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine 74: 350-358, 1995.
4. Belenfant X, Meyrier A, Jacquot C. Supportive treatnient improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 33: 840-850, 1999.
5. Scolari F, Tardanico R, Zani R. et al. Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 36: 1089-1109, 2000.
6. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: A prospective study. J Am Soc Nephrol 14: 1584-1590, 2003.
7. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol 122: 1194-1198, 1986.
8. Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens 14: 831-834, 2001.
9. Nakahama H, Sakaguchi K. Small dose oral corticosteroid treatment rapidly improved renal function in a patient with an acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant 16: 872-973, 2001.
10. Tamura K, Umemura M, Yano H, et al. Acute rend faiture due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol 7; 67-71, 2003.
11. Motegi S, Abe M, Shimizu A, et al. Cholesterol trystal embolization: Skin manifestation, gastrointestinal and central nervous symptom - treated with corticosteroid. J Dermatol 32: 295-298, 2005.
12. Tsunoda S, Daimon S, Miyazaki R, Fujii H, Inazu A, Mabuchi H. LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism. Nephrol Dial Transplant 14: 1041-1042, 1999.